LRMR - Larimar Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

LRMR is currently covered by 7 analysts with an average price target of $38.04. This is a potential upside of $34 (841.58%) from yesterday's end of day stock price of $4.04.

Larimar Therapeutics's activity chart (see below) currently has 55 price targets and 66 ratings on display. The stock rating distribution of LRMR is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 29.41% with an average time for these price targets to be met of 242.41 days.

Highest price target for LRMR is $21, Lowest price target is $7, average price target is $13.8.

Most recent stock forecast was given by ANDREAS ARGYRIDES from OPPENHEIMER on 01-Oct-2025. First documented stock forecast 19-Mar-2015.

Currently out of the existing stock ratings of LRMR, 17 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$21

$16.79 (398.81%)

$26

29 days ago
(01-Oct-2025)

0/2 (0%)

$16.72 (390.65%)

Buy

$7

$2.79 (66.27%)

$10

1 months 1 days ago
(29-Sep-2025)

0/4 (0%)

$3.77 (116.72%)

Buy

$11

$6.79 (161.28%)

1 months 1 days ago
(29-Sep-2025)

0/2 (0%)

$7.77 (240.56%)

Buy

$18

$13.79 (327.55%)

$18

2 months 12 days ago
(18-Aug-2025)

1/12 (8.33%)

$14.35 (393.15%)

728

Buy

4 months 6 days ago
(24-Jun-2025)

2/4 (50%)

$17.17 (219.28%)

411

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is LRMR (Larimar Therapeutics) average time for price targets to be met?

On average it took 242.41 days on average for the stock forecasts to be realized with a an average price target met ratio 29.41

Which analyst has the current highest performing score on LRMR (Larimar Therapeutics) with a proven track record?

JASON BUTLER

Which analyst has the most public recommendations on LRMR (Larimar Therapeutics)?

Jason Butler works at JMP and has 6 price targets and 4 ratings on LRMR

Which analyst is the currently most bullish on LRMR (Larimar Therapeutics)?

Phil Nadeau with highest potential upside - $235.79

Which analyst is the currently most reserved on LRMR (Larimar Therapeutics)?

Edward Tenthoff with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?